Oramed Pharmaceuticals Files 8-K: Material Agreement
Ticker: ORMP · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1176309
| Field | Detail |
|---|---|
| Company | Oramed Pharmaceuticals Inc. (ORMP) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
Related Tickers: ORAM
TL;DR
ORAM filed an 8-K for a material definitive agreement - check for details.
AI Summary
On July 22, 2025, Oramed Pharmaceuticals Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates a significant new agreement for Oramed Pharmaceuticals, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Numbers
- 001-35813 — SEC File Number (Identifies the company's filing history with the SEC.)
- 98-0376008 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- ORAMED PHARMACEUTICALS INC. (company) — Registrant
- July 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Principal business address
FAQ
What is the nature of the material definitive agreement?
The filing indicates a material definitive agreement was entered into, but the specific details of the agreement are not provided in the provided text excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 22, 2025.
Where is Oramed Pharmaceuticals Inc. incorporated?
Oramed Pharmaceuticals Inc. is incorporated in Delaware.
What is the principal business address of Oramed Pharmaceuticals Inc.?
The principal business address is 1185 Avenue of the Americas, Third Floor, New York, New York, 10036.
What is the SEC file number for Oramed Pharmaceuticals Inc.?
The SEC file number is 001-35813.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding ORAMED PHARMACEUTICALS INC. (ORMP).